SynthioLabs
Latest round
- Seed
Last raised
- Nov 2025
Total raised
- $5M
Investors
- 5
About SynthioLabs
SynthioLabs, founded in 2024, operates in San Francisco, US, focusing on AI applications for the life sciences sector. The company has successfully completed 1 deal, with the most recent closing on June 4, 2025. The founder's details are not provided. SynthioLabs, founded in 2024, operates in San Francisco, US, focusing on AI applications for the life sciences sector. The company has successfully completed 1 deal, with the most recent closing on June 4, 2025. The founder's details are not provided. SynthioLabs offers a pioneering suite of AI-powered solutions specifically designed for physician engagement within the life sciences sector. Central to their offerings is Nexa, an AI Medical Expert that facilitates compliant and science-driven interactions between pharmaceutical companies and healthcare professionals. This platform enhances healthcare provider outreach by delivering tailored insights, clinical guidelines, and appointment scheduling capabilities, allowing field teams to engage effectively with physicians. The product suite also includes Synthio Polaris, which empowers organizations to create custom AI agents for diverse applications such as medical information automation, patient support, and HCP engagement.The revenue model of SynthioLabs is primarily structured around B2B transactions, where pharmaceutical companies subscribe to their AI platform services. Clients enter into partnerships that include access to Nexa and Synthio Polaris, with pricing determined by the scale of usage and specific features utilized. Revenue is generated through these subscriptions, alongside potential service fees for bespoke AI development or enhanced functionality tailored to individual client needs. By maintaining an enterprise-ready architecture, SynthioLabs ensures that its products meet the compliance and security requirements of its clients, adding further value to their offerings. Additionally, SynthioLabs aims to expand its market presence in Europe and Asia by the end of 2026, seeking to establish new partnerships and enhance its service distribution in these regions.
Who invested in SynthioLabs
5 investors across 2 rounds
See all investors in SynthioLabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SynthioLabs
Who invested in SynthioLabs?
SynthioLabs has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SynthioLabs raised?
SynthioLabs has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SynthioLabs last raise money?
SynthioLabs's most recent round on record is a Seed, in Nov 2025.
What does SynthioLabs do?
SynthioLabs, founded in 2024, operates in San Francisco, US, focusing on AI applications for the life sciences sector.
Where is SynthioLabs headquartered?
SynthioLabs is headquartered in San Francisco, US.
Which VCs invest in companies like SynthioLabs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at SynthioLabs's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like SynthioLabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.